BCL2L1 and central nervous system cancer: The SSO approach was documented to exert pro-apoptotic and chemosensitizing effects on a wide range of cell models, especially glioma cells, by shifting Bcl-x pre-mRNA splicing from the Bcl-xl to the Bcl-xs transcript [88].